Clinical Trial Detail

NCT ID NCT00461773
Title Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications

breast adenocarcinoma

Therapies

Letrozole

Bevacizumab

Age Groups: adult

No variant requirements are available.